NEW YORK (GenomeWeb) – Streck announced late last week that it has signed a distribution agreement for its cell stabilization, molecular, and core products with Philippines-based life sciences products distribution firm Golden Bat Far East.
Cell stabilization products covered in the deal include Streck's Cyto-Chex BCT, a blood collection tube for the preservation of whole blood specimens for immunophenotyping by flow cytometry; Cell-Free DNA BCT, a direct-draw blood collection tube that stabilizes nucleated blood cells and prevents the release of genomic DNA; Cell-Free RNA BCT, a blood collection tube with a preservative that stabilizes circulating RNA in plasma and prevents the release of non-target background RNA from blood cells during sample processing and storage; and Cell-Free DNA Urine Preserve, a liquid reagent that stabilizes cell-free DNA in urine.
Streck's molecular products include its ARM-D Kits for the detection of antibiotic resistance genes by multiplex real-time PCR and the not-yet-launched rapid real-time PCR instrument Zulu RT. The firm's core product portfolio includes control products that test the performance and limits of instruments and reagents.
Additional terms of the deal were not disclosed.
Streck has signed a number of distribution deals for its products in recent months, including one earlier this month with Indonesian firm Biozatix.